Arkolith/Insider Trading/CBIO/Form 4

Doughty Christopher Grant

Chief Business OfficerCRESCENT BIOPHARMA, INC. (CBIO) · full profile →Form 4 · filed Dec 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2025Grant(A)15K——54K
Dec 15, 2025Grant(A)8K——62K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2025Grant(A)59K—$059K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-25-057685) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML